Back to search
FDAFDA · Food and drugs·Recall number D-0036-2025

Morphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-185-01.

Published November 13, 2024 · Recall initiated: October 22, 2024

Summary

FDA records drug Class II recall D-0036-2025, published November 13, 2024 and initiated October 22, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 2,040 100-count bottles; Lot: Lot# FG14062, Exp 10/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specification

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA
Lot
Lot# FG14062, Exp 10/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-185-01. recalled?

Yes. FDA published recall D-0036-2025 on November 13, 2024. Reported hazard: Failed Impurities/Degradation Specification

What should I do if I have this product?

Voluntary: Firm initiated